- Xebra Brands has revealed a manufacturing non-exclusive agreement with KannaGroup to bring premium CBD products to Mexico
- The partnership will strengthen Xebra Brands’ footprint in the Mexican market by optimizing operational efficiencies and reducing production costs
- Through the partnership, three flagship products will be launched including tinctures, capsules and topicals
- Shares of Xebra Brands are 7.14 per cent to C$0.075 as of 9:52 am ET
Xebra Brands (CSE:XBRA) has revealed a manufacturing non-exclusive agreement with KannaGroup that will bring premium CBD products to Mexico.
In a news release, the Vancouver-based company stated the partnership will strengthen its footprint in the Mexican market by optimizing operational efficiencies and reducing production costs.
“We are thrilled to announce this strategic collaboration with KannaGroup, which represents a significant step forward in our growth journey,” Rodrigo Gallardo, CEO of Xebra Brands, said in a statement. “This partnership underscores our relentless pursuit of excellence and shareholder value creation as we continue to position Xebra Brands for sustained success in the dynamic CBD market landscape.
As such, the partnership will launch three flagship products in Mexico, including tinctures, capsules and topicals.
The tinctures are available in a range of strengths and flavours and are made using premium-quality CBD extract. The company’s capsules deliver precise doses of CBD, while the topicals offer targeted relief for the skin.
KannaGroup is a wellness company focused on the wellness markets in Mexico, Latin America and the U.S. Hispanic region.
Xebra Brands is an International cannabis company focused on the development and sale of cannabis and CBD products in Mexico and is a first-mover in the country with the first authorization to a corporation.
Shares of Xebra Brands (CSE:XBRA) are 7.14 per cent to C$0.075 as of 9:52 am ET.
Join the discussion: Find out what everybody’s saying about this stock on the Xebra Brands Bullboard investor discussion forum, and check out the rest of Stockhouse’s stock forums and message boards.
The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.